117 related articles for article (PubMed ID: 15750631)
1. Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells.
Bhatia B; Tang S; Yang P; Doll A; Aumüeller G; Newman RA; Tang DG
Oncogene; 2005 May; 24(22):3583-95. PubMed ID: 15750631
[TBL] [Abstract][Full Text] [Related]
2. 15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size).
Tang DG; Bhatia B; Tang S; Schneider-Broussard R
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):135-46. PubMed ID: 17164141
[TBL] [Abstract][Full Text] [Related]
3. Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells.
Tang S; Bhatia B; Zhou J; Maldonado CJ; Chandra D; Kim E; Fischer SM; Butler AP; Friedman SL; Tang DG
Oncogene; 2004 Sep; 23(41):6942-53. PubMed ID: 15247906
[TBL] [Abstract][Full Text] [Related]
4. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.
Xin H; Curry J; Johnstone RW; Nickoloff BJ; Choubey D
Oncogene; 2003 Jul; 22(31):4831-40. PubMed ID: 12894224
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants.
Bhatia B; Maldonado CJ; Tang S; Chandra D; Klein RD; Chopra D; Shappell SB; Yang P; Newman RA; Tang DG
J Biol Chem; 2003 Jul; 278(27):25091-100. PubMed ID: 12704195
[TBL] [Abstract][Full Text] [Related]
6. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells.
Tang S; Bhatia B; Maldonado CJ; Yang P; Newman RA; Liu J; Chandra D; Traag J; Klein RD; Fischer SM; Chopra D; Shen J; Zhau HE; Chung LW; Tang DG
J Biol Chem; 2002 May; 277(18):16189-201. PubMed ID: 11839751
[TBL] [Abstract][Full Text] [Related]
7. Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence.
Suraneni MV; Schneider-Broussard R; Moore JR; Davis TC; Maldonado CJ; Li H; Newman RA; Kusewitt D; Hu J; Yang P; Tang DG
Oncogene; 2010 Jul; 29(30):4261-75. PubMed ID: 20514017
[TBL] [Abstract][Full Text] [Related]
8. Intermediate basal cells of the prostate: in vitro and in vivo characterization.
Garraway LA; Lin D; Signoretti S; Waltregny D; Dilks J; Bhattacharya N; Loda M
Prostate; 2003 May; 55(3):206-18. PubMed ID: 12692787
[TBL] [Abstract][Full Text] [Related]
9. Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.
Li H; Zhou J; Miki J; Furusato B; Gu Y; Srivastava S; McLeod DG; Vogel JC; Rhim JS
Exp Cell Res; 2008 Jan; 314(1):92-102. PubMed ID: 17900565
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
11. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
12. Function of JunB in transient amplifying cell senescence and progression of human prostate cancer.
Konishi N; Shimada K; Nakamura M; Ishida E; Ota I; Tanaka N; Fujimoto K
Clin Cancer Res; 2008 Jul; 14(14):4408-16. PubMed ID: 18628455
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of APE1/Ref-1 is involved in the senescence of mesenchymal stem cells.
Heo JY; Jing K; Song KS; Seo KS; Park JH; Kim JS; Jung YJ; Hur GM; Jo DY; Kweon GR; Yoon WH; Lim K; Hwang BD; Jeon BH; Park JI
Stem Cells; 2009 Jun; 27(6):1455-62. PubMed ID: 19492297
[TBL] [Abstract][Full Text] [Related]
14. Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer.
Untergasser G; Koch HB; Menssen A; Hermeking H
Cancer Res; 2002 Nov; 62(21):6255-62. PubMed ID: 12414655
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer.
Suraneni MV; Moore JR; Zhang D; Badeaux M; Macaluso MD; DiGiovanni J; Kusewitt D; Tang DG
Cell Cycle; 2014; 13(11):1798-810. PubMed ID: 24732589
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia.
Castro P; Xia C; Gomez L; Lamb DJ; Ittmann M
Prostate; 2004 Jul; 60(2):153-9. PubMed ID: 15162381
[TBL] [Abstract][Full Text] [Related]
17. In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue.
Uzgare AR; Xu Y; Isaacs JT
J Cell Biochem; 2004 Jan; 91(1):196-205. PubMed ID: 14689591
[TBL] [Abstract][Full Text] [Related]
18. Effects of donor age on the expression of a marker of replicative senescence (EPC-1) in human dermal fibroblasts.
Tresini M; Pignolo RJ; Allen RG; Cristofalo VJ
J Cell Physiol; 1999 Apr; 179(1):11-7. PubMed ID: 10082127
[TBL] [Abstract][Full Text] [Related]
19. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.
Patrawala L; Calhoun T; Schneider-Broussard R; Li H; Bhatia B; Tang S; Reilly JG; Chandra D; Zhou J; Claypool K; Coghlan L; Tang DG
Oncogene; 2006 Mar; 25(12):1696-708. PubMed ID: 16449977
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
